FGF2 and leukemia: Besides, oncostatin M has been reported to replace by leukemia inhibitory factor for differentiating bone marrow-derived MSCs toward hepatocyte lineage.30 However, there are a few number of researches focusing on Wharton’s jelly MSCs differentiation toward hepatocyte; but it has been shown that they could differentiate into hepatocyte by treating with HGF, OSM along with FGF-423 or bFGF.11